Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial found using a bilateral attack achieves a more robust defense and helps avoid relapse.
Forschungsgruppe Quanteneffekte bei Krankheiten (qrdrg.xonl.de)
Copyright © 2024 MEDIZIN.NEWZS.de - Quantum Related Diseases Research Group (QRDRG)